ABMT (Advanced BioMedical Technologies) Ending Cash Position: $0.01 Mil (As of Jul. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced BioMedical Technologies Ending Cash Position?

Advanced BioMedical Technologies ABMT Ending Cash Position is $0.01 Mil as of Jul. 2021.

Advanced BioMedical Technologies's Ending Cash Position for the quarter that ended in Jul. 2021 was $0.01 Mil.

Advanced BioMedical Technologies's quarterly Ending Cash Position declined from Jan. 2021 ($0.01 Mil) to Apr. 2021 ($0.01 Mil) but then increased from Apr. 2021 ($0.01 Mil) to Jul. 2021 ($0.01 Mil).

Advanced BioMedical Technologies's annual Ending Cash Position declined from Oct. 2018 ($0.01 Mil) to Oct. 2019 ($0.01 Mil) but then increased from Oct. 2019 ($0.01 Mil) to Oct. 2020 ($0.20 Mil).

Advanced BioMedical Technologies Ending Cash Position Related Terms

Advanced BioMedical Technologies Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Ending Cash Position Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.20

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.20 0.01 0.01 0.01

Advanced BioMedical Technologies Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Advanced BioMedical Technologies's Ending Cash Position for the fiscal year that ended in Oct. 2020 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.0059999999999999+0.196
=0.20

Advanced BioMedical Technologies's Ending Cash Position for the quarter that ended in Jul. 2021 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.006+0.001
=0.01

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.01 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Ending Cash Position of $0.01 Mil as of Jul. 2021. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Ending Cash Position too high?
Advanced BioMedical Technologies' current Ending Cash Position is $0.01 Mil.
How does Advanced BioMedical Technologies' Ending Cash Position compare to VYCO and ADMT?
Advanced BioMedical Technologies' Ending Cash Position of $0.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Ending Cash Position is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Ending Cash Position of $0.01 Mil. The current Ending Cash Position is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Ending Cash Position is $0.01 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.